Eligibility depends on current program criteria, your Medicare drug coverage, your BMI and weight history, your medical diagnoses, and whether the required documentation is available
sitagliptin Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
Han, Y., Park, H., Choi, B
Justice remembered
By one year, more than 40% of participants had lost at least 20% of their body weight
Endometriosis isn't simply just some rogue tissue growing outside of the uterus and causing you to have period pain
